Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.41B |
| 2 |
Microchip Technology
MCHP
|
+$691M |
| 3 |
Microsoft
MSFT
|
+$554M |
| 4 |
PepsiCo
PEP
|
+$534M |
| 5 |
Sunoco
SUN
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$649M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$490M |
| 3 |
NS
NuStar Energy L.P.
NS
|
+$431M |
| 4 |
Flutter Entertainment
FLUT
|
+$424M |
| 5 |
UDR
UDR
|
+$392M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.83% |
| 2 | Financials | 11.94% |
| 3 | Industrials | 11.45% |
| 4 | Healthcare | 10.48% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LNKB
3701
DELISTED
LINKBANCORP
LNKB
| $61.3K | ﹤0.01% |
+10,016
| New | +$64.5K |
|
3702
FibroBiologics
FBLG
$4.37M
| $61.3K | ﹤0.01% |
+614
| New | +$117K |
|
3703
Trevi Therapeutics
TRVI
$2.61B
| $58.8K | ﹤0.01% |
19,723
-165
| -0.8% | -$458 |
|
3704
ASP Isotopes
ASPI
$501M
| $58.5K | ﹤0.01% |
+19,126
| New | +$73.8K |
|
3705
Solid Biosciences
SLDB
$836M
| $58.2K | ﹤0.01% |
10,258
-461,849
| -98% | -$4.14M |
|
3706
Capricor Therapeutics
CAPR
$243M
| $57.9K | ﹤0.01% |
+12,134
| New | +$67.7K |
|
|
GOEV
3707
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $57.3K | ﹤0.01% |
+1,345
| New | +$65.8K |
|
3708
X4 Pharmaceuticals
XFOR
$377M
| $57.2K | ﹤0.01% |
3,286
-1
| -0% | -$33 |
|
|
ALIM
3709
DELISTED
Alimera Sciences
ALIM
| $57.1K | ﹤0.01% |
+10,266
| New | +$36.5K |
|
|
AUTL
3710
Autolus Therapeutics
AUTL
$407M
| $56.8K | ﹤0.01% |
16,324
+5,253
| +47% | +$22.7K |
|
3711
Lineage Cell Therapeutics
LCTX
$277M
| $56.6K | ﹤0.01% |
56,764
+15
| +0% | +$17 |
|
3712
Porch Group
PRCH
$1.63B
| $56.2K | ﹤0.01% |
+37,248
| New | +$104K |
|
3713
Denison Mines
DNN
$2.64B
| $55.7K | ﹤0.01% |
27,972
-26
| -0.1% | -$55 |
|
3714
Cadiz
CDZI
$264M
| $55.1K | ﹤0.01% |
17,835
+12
| +0.1% | +$33 |
|
3715
Rekor Systems
REKR
$84.6M
| $52.8K | ﹤0.01% |
+34,056
| New | +$59.6K |
|
3716
Veru
VERU
$35.6M
| $52.8K | ﹤0.01% |
+6,272
| New | +$72.6K |
|
3717
Biomea Fusion
BMEA
$88.2M
| $52.6K | ﹤0.01% |
11,693
+1,228
| +12% | +$12.5K |
|
3718
1stdibs.com
DIBS
$147M
| $52.5K | ﹤0.01% |
+11,682
| New | +$63.8K |
|
|
RGLS
3719
DELISTED
Regulus Therapeutics
RGLS
| $51.9K | ﹤0.01% |
+29,061
| New | +$67.4K |
|
3720
BlackSky Technology
BKSY
$919M
| $51.8K | ﹤0.01% |
6,048
-743
| -11% | -$6.97K |
|
3721
MeiraGTx Holdings
MGTX
$1.11B
| $51.2K | ﹤0.01% |
12,166
-6,627
| -35% | -$33.4K |
|
3722
CDT Equity Inc
CDT
$1.69M
| – | – |
0
| – | – |
|
3723
Nautilus Biotechnolgy
NAUT
$131M
| $49.7K | ﹤0.01% |
21,245
-1,817
| -8% | -$4.74K |
|
3724
Aemetis
AMTX
$110M
| $49.4K | ﹤0.01% |
+16,399
| New | +$62.5K |
|
3725
ThredUp
TDUP
$757M
| $49.2K | ﹤0.01% |
28,927
-2,619
| -8% | -$4.77K |
|
Similar funds
Invesco's Q2 2024 Portfolio in Review
As of Q2 2024, Invesco held 4,042 positions worth $473B, up 1.6% from $466B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Invesco's Q2 2024 filing shows 191 new, 1,771 increased, 1,786 reduced and 173 closed positions. Its largest new stake was Solventum: 3,404,015 shares worth $180M. The largest sale was NVIDIA, an estimated $649M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Industrials.
- Invesco's largest Q2 2024 buy was Solventum: 3,404,015 shares worth $180M.
- Invesco added most to Apple in Q2 2024, an estimated $1.41B increase.
- Invesco's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $649M.
- Invesco fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $490M.
- Invesco's ten largest holdings make up 18% of its $473B portfolio in Q2 2024.
- Invesco opened 191 new positions and closed 173 in Q2 2024.
- Invesco's portfolio value rose 1.6% quarter-over-quarter to $473B.
Based on Invesco's 13F filing for Q2 2024, filed 13 Aug 2024.